Chinese english Germany Japanese Korea

1-[(5-oxo-1-phenylpyrrolidin-3-yl)carbonyl]piperidine-4-carboxylic acid

1-[(5-oxo-1-phenylpyrrolidin-3-yl)carbonyl]piperidine-4-carboxylic acid Struktur
1010873-30-9
CAS-Nr.
1010873-30-9
Englisch Name:
1-[(5-oxo-1-phenylpyrrolidin-3-yl)carbonyl]piperidine-4-carboxylic acid
Synonyma:
4-piperidinecarboxylic acid, 1-[(5-oxo-1-phenyl-3-pyrrolid;1-(5-Oxo-1-phenyl-pyrrolidine-3-carbonyl)-piperidine-4-carboxylic acid;1-[(5-oxo-1-phenylpyrrolidin-3-yl)carbonyl]piperidine-4-carboxylic acid;4-piperidinecarboxylic acid, 1-[(5-oxo-1-phenyl-3-pyrrolidinyl)carbonyl]-
CBNumber:
CB22132309
Summenformel:
C17H20N2O4
Molgewicht:
316.35
MOL-Datei:
1010873-30-9.mol
Request For Quotation

1-[(5-oxo-1-phenylpyrrolidin-3-yl)carbonyl]piperidine-4-carboxylic acid Eigenschaften

Sicherheit

HazardClass  IRRITANT

1-[(5-oxo-1-phenylpyrrolidin-3-yl)carbonyl]piperidine-4-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

1-[(5-oxo-1-phenylpyrrolidin-3-yl)carbonyl]piperidine-4-carboxylic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-[(5-oxo-1-phenylpyrrolidin-3-yl)carbonyl]piperidine-4-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 6)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Combi-Blocks Inc. --
 sales@combi-blocks.com United States 6632 69
Matrix Scientific --
 sales@matrixscientific.com United States 6655 80
Syntechem Co.,Ltd --
 - China 6193 58
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6178 60
Princeton BioMolecular Research, Inc. --
 info@princetonbio.com United States 6935 51
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6350 50
  • 4-piperidinecarboxylic acid, 1-[(5-oxo-1-phenyl-3-pyrrolid
  • 1-[(5-oxo-1-phenylpyrrolidin-3-yl)carbonyl]piperidine-4-carboxylic acid
  • 4-piperidinecarboxylic acid, 1-[(5-oxo-1-phenyl-3-pyrrolidinyl)carbonyl]-
  • 1-(5-Oxo-1-phenyl-pyrrolidine-3-carbonyl)-piperidine-4-carboxylic acid
  • 1010873-30-9
Copyright 2019 © ChemicalBook. All rights reserved